Growing up in the genomic era: Implications of whole-genome sequencing for children, families, and pediatric practice

Annual Review of Genomics and Human Genetics

Volumn 14, Issue , 2013, Pages 535-555

  Wade, Christopher H ^a   Tarini, Beth A ^b   Wilfond, Benjamin S ^c,d  

^a UNIVERSITY OF WASHINGTON BOTHELL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ELSI; ethical, legal, and social implications; Genetic testing; newborn screening; pediatrics; policy

Indexed keywords

CHILD HEALTH; CLINICAL PRACTICE; GENE SEQUENCE; GENETIC RISK; GENETIC SCREENING; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; HUMAN GENOME; INDEL MUTATION; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; NEWBORN SCREENING; PEDIATRICS; REVIEW; STRATEGIC PLANNING; WELLBEING;

CHILD; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PEDIATRICS; SEQUENCE ANALYSIS, DNA;

EID: 84884301445     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-091212-153425     Document Type: Review

References (113)

1. Alexander D, Van Dyck PC. 2006. A vision of the future of newborn screening. Pediatrics 117:S350-54
2. Almond B. 2006. Genetic profiling of newborns: Ethical and social issues. Nat. Rev. Genet. 7:67-71
3. AndermannA, Blancquaert I, Beauchamp S, DéryV. 2008. Revisiting Wilson and Jungner in the genomic age: A review of screening criteria over the past 40 years. Bull. World Health Organ. 86:317-19
4. Ball MP, Thakuria JV, Zaranek AW, Clegg T, Rosenbaum AM, et al. 2012. A public resource facilitating clinical use of genomes. Proc. Natl. Acad. Sci. USA 109:11920-27
5. Berg JS, KhouryMJ, Evans JP. 2011. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genet. Med. 13:499-504
6. Bick D, Dimmock D. 2011. Whole exome and whole genome sequencing. Curr. Opin. Pediatr. 23:594-600
7. Biesecker LG. 2012. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: Lessons from the ClinSeq project. Genet. Med. 14:393-98
8. Bloss CS, Schork NJ, Topol EJ. 2011. Effect of direct-To-consumer genomewide profiling to assess disease risk. N. Engl. J. Med. 364:524-34
9. Borry P, Fryns JP, Schotsmans P, Dierickx K. 2005. Attitudes towards carrier testing in minors: A systematic review. Genet. Couns. 16:341-52
10. Borry P, Fryns JP, Schotsmans P, Dierickx K. 2006. Carrier testing in minors: A systematic review of guidelines and position papers. Eur. J. Hum. Genet. 14:133-38
11. Borry P, Goffin T, Nys H, Dierickx K. 2008. Predictive genetic testing in minors for adult-onset genetic diseases. Mt. Sinai J. Med. 75:287-96
12. Borry P, Howard HC, Senecal K, Avard D. 2009. Health-related direct-To-consumer genetic testing: A review of companies' policies with regard to genetic testing in minors. Fam. Cancer 9:51-59
13. Borry P, Stultiëns L, Goffin T, NysH, Dierickx K. 2008. Minors and informed consent in carrier testing: A survey of European clinical geneticists. J. Med. Ethics 34:370-74
14. Borry P, Stultiëns L, Nys H, Cassiman JJ, Dierickx K. 2006. Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clin. Genet. 70:374-81
15. Borry P, Stultiëns L, Nys H, Dierickx K. 2007. Attitudes towards predictive genetic testing in minors for familial breast cancer: A systematic review. Crit. Rev. Oncol. Hematol. 64:173-81
16. Brunham LR, Hayden MR. 2012. Whole-genome sequencing: The new standard of care? Science 336:1112-13
17. Collins FS. 2010. The Language of Life: DNA and the Revolution in Personalized Medicine. New York: HarperCollins
18. Comm. Bioeth., Comm. Genet., Am. Coll. Med. Genet. Genomics Soc. Ethical Leg. Issues Comm. 2013. Ethical and policy issues in genetic testing and screening of children. Pediatrics 131:620-22
19. Condit CM. 2010. Public attitudes and beliefs about genetics. Annu. Rev. Genomics Hum. Genet. 11:339-59
20. Davies K. 2010. The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine. New York: Free Press
21. Diekema DS. 2004. Parental refusals of medical treatment: The harm principle as threshold for state intervention. Theor. Med. Bioeth. 25:243-64
22. Downing JR, Wilson RK, Zhang J, Mardis ER, Pui C-H, et al. 2012. The Pediatric Cancer Genome Project. Nat. Genet. 44:619-22
23. Driessnack M, Gallo AM. 2011. Stop, look, and listen: Revisiting the involvement of children and adolescents in genomic research. Annu. Rev. Nurs. Res. 29:133-49
24. Drmanac R. 2012. The ultimate genetic test. Science 336:1110-12
25. Duncan RE, Delatycki MB. 2006. Predictive genetic testing in young people for adult-onset conditions: Where is the empirical evidence? Clin. Genet. 69:8-16
26. Duncan RE, Savulescu J, Gillam L, Williamson R, Delatycki MB. 2005. An international survey of predictive genetic testing in children for adult onset conditions. Genet. Med. 7:390-96
27. Eisenberg D, Freed GL. 2007. Reassessing how society prioritizes the health of young people. Health Aff. 26:345-54
28. Elger BS. 2010. Ethical, legal, and social issues in the genetic testing of minors. See Ref. 99, pp. 485-522
29. Facio FM, Eidem H, Fisher T, Brooks S, Linn A, et al. 2013. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. Eur. J. Hum. Genet. 21:261-65
30. Fanos JH. 1997. Developmental tasks of childhood and adolescence: Implications for genetic testing. Am. J. Med. Genet. 71:22-28
31. Fanos JH, Wiener L, Brennan T. 2010. Potential impact of genomic information on childhood sibling relationships. See Ref. 99, pp. 141-61
32. Fed. Am. Sci. Exp. Biol. 2012. Engaging Basic Scientists in Translational Research: Identifying Opportunities, Overcoming Obstacles. Bethesda, MD: Fed. Am. Sci. Exp. Biol
33. Feero WG, Green ED. 2011. Genomics education for health care professionals in the 21st century. JAMA 306:989-90
34. Fields MJ, Behrman RE. 2004. The Ethical Conduct of Clinical Research Involving Children. Washington, DC: Inst. Med. Natl. Acad
35. Gahl WA, Markello TC, Toro C, Fajardo KF, Sincan M, et al. 2012. The National Institutes of Health Undiagnosed Diseases Program: Insights into rare diseases. Genet. Med. 14:51-59
36. Glasgow RE, Green LW, Taylor MV, Stange KC. 2012. An evidence integration triangle for aligning science with policy and practice. Am. J. Prev. Med. 42:646-54
37. Goldenberg AJ, Sharp RR. 2012. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 307:461-62
38. Greb A. 1998. Multiculturalism and the practice of genetic counseling. In A Guide to Genetic Counseling, ed. DL Baker, JL Schuette, WR Uhlmann, pp. 171-98. New York: Wiley-Liss
39. Green ED, Guyer MS. 2011. Charting a course for genomic medicine from base pairs to bedside. Nature 470:204-13
40. Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, et al. 2012. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet. Med. 14:405-10
41. Griffith GM, Hastings RP, Oliver C, Howlin P, Moss J, et al. 2011. Psychological well-being in parents of children with Angelman, Cornelia De Lange and Cri du Chat syndromes. J. Intellect. Disabil. Res. 55:397-410
42. Haddow JE, Palomaki GE. 2003. ACCE: A model process for evaluating data on emerging genetic tests. In Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease, ed. MJ Khoury, J Little, WBurke, pp. 217-33. Oxford, UK: Oxford Univ. Press
43. HadleyDW, Ersig ADL, QuattrocchiMKH. 2010. Guidelines and policies on genetic testing in children and families. See Ref. 99, pp. 523-57
44. Haga SB, Terry SF. 2009. Ensuring the safe use of genomicmedicine in children. Clin. Pediatr. 48:703-8
45. Hall HR, Neely-Barnes SL, Graff JC, Krcek TE, Roberts RJ, et al. 2012. Parental stress in families of children with a genetic disorder/disability and the resiliency model of family stress, adjustment, and adaptation. Issues Compr. Pediatr. Nurs. 35:24-44
46. Hum.Genet. Comm.,UKNatl. Screen.Comm.2005. Profiling theNewborn: AProspective Gene Technology. London: Hum. Genet. Comm. and UK Natl. Screen. Comm
47. Inst.Med. Natl. Acad. 2008. Innovations in Service Delivery in the Age of Genomics. Washington, DC: Inst. Med. Natl. Acad
48. Inst. Med. Natl. Acad. 2012. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: Inst. Med. Board Health Care Serv
49. Izraeli S. 2010. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: From bench to bedside? Br. J. Haematol. 151:119-31
50. Kaye CI. 2012. Genetic service delivery: Infrastructure, assessment and information. Public Health Genomics 15:164-71
51. Koehly LM, McBride CM. 2010. Genomic risk information for common health conditions: Maximizing kinship-based health promotion. See Ref. 99, pp. 407-36
52. Koehly LM, Peters JA, Kuhn N, Hoskins L, Letocha A, et al. 2008. Sisters in hereditary breast and ovarian cancer families: Communal coping, social integration, and psychological well-being. Psychooncology 17:812-21
53. Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, et al. 2003. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol. Biomark. Prev. 12:304-13
54. Kohane IS, Hsing M, Kong SW. 2012. Taxonomizing, sizing, and overcoming the incidentalome. Genet. Med. 14:399-404
55. Kolata G. 2013. DNA test for rare disorders becomes more routine. N. Y. Times, Feb. 18. http://www. nytimes.com/2013/02/19/health/dna-Analysis-more- Accessible-Than-ever-opens-new-Doors. html
56. Laedtke AL, O'Neill SM, Rubinstein WS, Vogel KJ. 2012. Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA). J. Genet. Couns. 21:345-52
57. Lerman C, Croyle RT, Tercyak KP, Hamann H. 2002. Genetic testing: Psychological aspects and implications. J. Consult. Clin. Psychol. 70:784-97
58. Lipinski SE, LipinskiMJ, Biesecker LG, Biesecker BB. 2006. Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling.Am. J. Med. Genet. C 142C:232-40
59. Lloyd-Puryear MA, Tonniges T, Van Dyck PC, Mann MY, Brin A, et al. 2006. American Academy of Pediatrics Newborn Screening Task Force recommendations: How far have we come? Pediatrics 117:S194-211
60. Malpas PJ. 2008. Predictive genetic testing of children for adult-onset diseases and psychological harm. J. Med. Ethics 34:275-78
61. Markel H. 1992. The stigma of disease: Implications of genetic screening. Am. J. Med. 93:209-15
62. Marteau TM. 1994. The genetic testing of children. J. Med. Genet. 31:743
63. Metcalfe A, Coad J, Plumridge GM, Gill P, Farndon P. 2008. Family communication between children and their parents about inherited genetic conditions: A meta-synthesis of the research. Eur. J. Hum. Genet. 16:1193-200
64. Miller FA, Hayeems RZ, Carroll JC, Wilson B, Little J, et al. 2010. Consent for newborn screening: The attitudes of health care providers. Public Health Genomics 13:181-90
65. Moore CA, Khoury MJ, Bradley LA. 2005. From genetics to genomics: Using gene-based medicine to prevent disease and promote health in children. Semin. Perinatol. 29:135-43
66. Natl. Inst. Child Health Hum. Dev. 2010. Newborn Screening in the Genomic Era: Setting a Research Agenda. Rockville, MD: Natl. Inst. Child Health Hum. Dev
67. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, et al. 2012. Clinical application of exome sequencing in undiagnosed genetic conditions. J. Med. Genet. 49:353-61
68. O'Daniel JM. 2010. The prospect of genome-guided preventive medicine: A need and opportunity for genetic counselors. J. Genet. Couns. 19:315-27
69. O'Daniel JM, McConkie-Rosell A. 2010. Process in genetic counseling: Considerations for children and their families. See Ref. 99, pp. 87-107
70. O'Neill SC, Peshkin BN, LutaG, Abraham A, Walker LR, et al. 2010. Primary care providers'willingness to recommend BRCA1/2 testing to adolescents. Fam. Cancer 9:43-50
71. Persky S, Kaphingst KA, Condit CM, McBride CM. 2007. Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: A quantitative review. Genet. Med. 9:727-38
72. Peshkin BN, DeMarco TA, Garber JE, ValdimarsdottirHB, Patenaude AF, et al. 2009. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: Development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). J. Pediatr. Psychol. 34:627-38
73. Peshkin BN, DeMarco TA, Tercyak KP. 2009. On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children. Fam. Cancer 9:89-97
74. Pres. Counc. Bioeth. 2008. The Changing Moral Focus of Newborn Screening: An Ethical Analysis by the President's Council on Bioethics. Washington, DC: Pres. Counc. Bioeth
75. Reid RJ, McBride CM, Alford SH, Price C, Baxevanis AD, et al. 2012. Association between health-service use and multiplex genetic testing. Genet. Med. 14:852-59
76. Rew L, Mackert M, Bonevac D. 2009. A systematic review of literature about the genetic testing of adolescents. J. Spec. Pediatr. Nurs. 14:284-94
77. Rhodes R. 2006. Why test children for adult-onset genetic diseases? Mt. Sinai J. Med. 73:609-16
78. Riper MV. 2010. Genomics and the family: Integrative frameworks. See Ref. 99, pp. 109-39
79. Roach JC, Glusman G, Hubley R, Montsaroff SZ, Holloway AK, et al. 2011. Chromosomal haplotypes by genetic phasing of human families. Am. J. Hum. Genet. 89:382-97
80. Rochman B. 2012. Test your DNA for diseases-no doctor required. Time, Oct. 23. http://healthland. time.com/2012/10/23/drugstore-genomes-whos-pushing- The-sequencing-industry
81. Rosas-Blum E, Shirsat P, Leiner M. 2007. Communicating genetic information: A difficult challenge for future pediatricians. BMC Med. Educ. 7:17
82. Ross LF. 2002. Predictive genetic testing for conditions that present in childhood. Kennedy Inst. Ethics J. 12:225-44
83. Ross LF. 2010. Mandatory versus voluntary consent for newborn screening? Kennedy Inst. Ethics J. 20:299-328
84. Ross LF, Saal HM, David KL, Anderson RR. 2013. Technical report: Ethical and policy issues in genetic testing and screening of children. Genet. Med. 15:234-45
85. Roth JA, Garrison LP Jr, Burke W, Ramsey SD, Carlson R, et al. 2011. Stakeholder perspectives on a risk-benefit framework for genetic testing. Public Health Genomics 14:59-67
86. Rowland E, Metcalfe A. 2013. Communicating inherited genetic risk between parent and child: A metathematic synthesis. Int. J. Nurs. Stud. 50:870-80
87. Saunders CJ, MillerNA, Soden SE, DinwiddieDL, Noll A, et al. 2012. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 4:154ra35
88. Scheuner MT, Sieverding P, Shekelle PG. 2008. Delivery of genomic medicine for common chronic adult diseases: A systematic review. JAMA 299:1320-34
89. Segal ME, Polansky M, Sankar P. 2007. Adults' values and attitudes about genetic testing for obesity risk in children. Int. J. Pediatr. Obes. 2:11-21
90. Shields AE, Burke W, Levy DE. 2008. Differential use of available genetic tests among primary care physicians in the United States: Results of a national survey. Genet. Med. 10:404-14
91. Solomon BD, Hadley DW, Pineda-Alvarez DE, Kamat A, Teer JK, et al. 2012. Incidental medical information in whole-exome sequencing. Pediatrics 129:e1605-11
92. Solomon BD, Pineda-Alvarez DE, Hadley DW, NISC Comp. Seq. Program, Teer JK, et al. 2011. Personalized genomic medicine: Lessons from the exome. Mol. Genet. Metab. 104:189-91
93. Sterling R, Henderson GE, Corbie-Smith G. 2006. Public willingness to participate in and public opinions about genetic variation research: A review of the literature. Am. J. Public Health 96:1971-78
94. Stone K. 2012. Genomic testing update: Whole genome sequencing may be worth the money. Ann. Neurol. 71:A7-9
95. Tabor HK, Stock J, Brazg T, McMillin MJ, Dent KM, et al. 2012. Informed consent for whole genome sequencing: A qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. Am. J. Med. Genet. A 158A:1310-19
96. Tarini BA, Goldenberg AJ. 2012. Ethical issues with newborn screening in the genomics era. Annu. Rev. Genomics Hum. Genet. 13:381-93
97. Tarini BA, Singer D, Clark SJ, Davis MM. 2009. Parents' interest in predictive genetic testing for their children when a disease has no treatment. Pediatrics 124:e432-38
98. Tarini BA, Tercyak KP, Wilfond BS. 2011. Commentary: Children and predictive genomic testing: Disease prevention, research protection, and our future. J. Pediatr. Psychol. 36:1113-21
99. Tercyak KP, Hensley Alford S, Emmons KM, Lipkus IM, Wilfond BS, et al. 2011. Parents' attitudes toward pediatric genetic testing for common disease risk. Pediatrics 127:e1288-95
100. Tercyak KP, Peshkin BN, DeMarco TA, Brogan BM, Lerman C. 2002. Parent-child factors and their effect on communicating BRCA1/2 results to children. Patient Educ. Couns. 47:145-53
101. Tercyak KP, Streisand R, Peshkin BN, Lerman C. 2000. Psychosocial impact of predictive testing for illness on children and families: Challenges for a new millennium. J. Clin. Psychol. Med. Settings 7:55-68
102. Townsend A, Adam S, Birch PH, Lohn Z, Rousseau F, et al. 2012. I want to know what's in Pandora's Box: Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. Am. J. Med. Genet. A 158A:2519-25
103. UnitedHealth Cent. Health Reform Mod. 2012. Personalized Medicine: Trends and Prospects for the New Science ofGenetic Testing andMolecular Diagnostics. Minnetonka, MN:UnitedHealthCent. HealthReform Mod
104. Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, et al. 2013. Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: An EGAPP methods update. Genet. Med. 15:14-24
105. Wade CH, Shiloh S, Roberts JS, Hensley Alford S, Marteau TM, et al. 2012. Preferences among diseases on a genetic susceptibility test forcommonhealth conditions: An ancillary study of theMultiplex Initiative. Public Health Genomics 15:322-26
106. Wade CH, Wilfond BS, McBride CM. 2010. Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literature. Genet. Med. 12:317-26
107. Wertz DC, Fanos JH, Reilly PR. 1994. Genetic testing for children and adolescents: Who decides? J. Am. Med. Assoc. 272:875-81
108. White DB, Bonham VL, Jenkins J, Stevens N, McBride CM. 2008. Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians. Cancer Epidemiol. Biomark. Prev. 17:2980-86
109. WilfondBS, Nolan K. 1993. National policy development for the clinical application of genetic diagnostic technologies: Lessons from cystic fibrosis. JAMA 270:2948-54
110. Wilfond BS, Ross LF. 2008. From genetics to genomics: Ethics, policy, and parental decision-making. J. Pediatr. Psychol. 34:639-47
111. Wilfond BS, Thomson EJ. 2003. Models of public health genetic policy development. In Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease, ed.MJ Khoury, WBurke, EJ Thomson, pp. 61-81. Oxford, UK: Oxford Univ. Press
112. Wilson BJ, Etchegary H. 2010. Family communication of genomic information. See Ref. 99, pp. 163-89
113. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. 2003. Primary care: Is there enough time for prevention? Am. J. Public Health 93:635-41 Development